Unity Biotechnology Inc. (UBX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.71
0.00 (0.00%)
At close: Jan 15, 2025, 3:59 PM
1.66
-2.92%
After-hours Jan 15, 2025, 06:21 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -39.86M | -59.93M | -60.73M | -93.84M | -82.18M | -76.40M | -44.66M | -30.40M |
Depreciation & Amortization | 1.18M | 2.18M | 2.88M | 3.45M | 2.66M | 2.18M | 1.30M | 153.00K |
Stock-Based Compensation | 7.42M | 9.38M | 11.55M | 13.81M | 10.85M | 9.44M | 3.03M | 224.00K |
Other Working Capital | -3.98M | -828.00K | -58.00K | -1.91M | 3.79M | 2.90M | 1.13M | 1.79M |
Other Non-Cash Items | -3.00M | -1.64M | 943.00K | 420.00K | -387.00K | 4.54M | 44.00K | 2.67M |
Deferred Income Tax | n/a | n/a | 920.00K | 2.38M | -6.93M | -1.51M | -408.00K | 8.97M |
Change in Working Capital | -4.39M | -1.02M | -631.00K | -4.55M | 3.56M | 5.13M | 2.32M | 1.99M |
Operating Cash Flow | -38.65M | -51.03M | -45.06M | -78.33M | -72.42M | -56.62M | -38.36M | -16.40M |
Capital Expenditures | -11.00K | -96.00K | -195.00K | -646.00K | -1.59M | -1.26M | -1.69M | -2.24M |
Acquisitions | n/a | 378.00K | -39.51M | 4.56M | -69.54M | n/a | n/a | n/a |
Purchase of Investments | -28.61M | -98.83M | -81.49M | -138.49M | -119.27M | -204.59M | -134.47M | -500.00K |
Sales Maturities Of Investments | 89.00M | 74.00M | 121.00M | 133.92M | 188.81M | 133.64M | 49.85M | n/a |
Other Investing Acitivies | 115.00K | -24.45M | 39.51M | -4.56M | 69.54M | -70.94M | -84.62M | -500.00K |
Investing Cash Flow | 60.49M | -24.55M | 39.31M | -5.21M | 67.95M | -72.21M | -86.31M | -2.74M |
Debt Repayment | -20.00M | n/a | -68.00K | 24.14M | -73.00K | 821.00K | -55.00K | 16.89M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -37.00K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.45M | -3.65M | 2.34M | 2.46M | 1.43M | 195.99M | 42.83M | 91.05M |
Financial Cash Flow | -16.34M | 54.85M | 20.84M | 63.88M | 27.44M | 136.93M | 42.77M | 107.94M |
Net Cash Flow | 7.07M | -20.72M | 15.10M | -19.67M | 22.97M | 8.10M | -81.89M | 88.80M |
Free Cash Flow | -37.10M | -51.13M | -45.26M | -78.98M | -74.01M | -57.89M | -40.05M | -18.64M |